Figure 1From: Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild typeThe IDH1 mutation-specific 23-miRNA signature. The 23 miRNAs were differentially expressed by more than 1.5 fold in GBM samples with mutant-type IDH1 compared to those with wild-type IDH1.Back to article page